AstraZeneca PLC — Director's Dealing 2021

Mar 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Viela Bio, Inc. (VIE)
CIK: 0001734517
Period of Report: 2021-03-15

Reporting Person: ASTRAZENECA PLC (10% Owner)
Reporting Person: AstraZeneca UK LTD (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-15	Common Stock	U	14650334	$53.00	Disposed	0	Indirect

Footnotes

F1: All of these securities are owned by AstraZeneca UK Limited, which is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to beneficially own the shares held by AstraZeneca UK Limited, but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any.